The role of anti-tumor necrosis factor receptor agents in cancer survivors: Does the risk justify the benefit? Journal Article


Authors: Chapman, P.; Cranmer, L.; Dixon, W. G.; Hyrich, K. L.; Patterson, J. R.; Symmons, D. P. M.; Toporcer, M.; Mastrangelo, M. J.
Article Title: The role of anti-tumor necrosis factor receptor agents in cancer survivors: Does the risk justify the benefit?
Keywords: placebo; lymphoma; malignancy; immunosurveillance; therapy; trial; monoclonal-antibody; receiving concomitant methotrexate; rheumatoid-arthritis
Journal Title: Seminars in Oncology
Volume: 37
Issue: 1
ISSN: 0093-7754
Publisher: Elsevier Inc.  
Date Published: 2010-02-01
Start Page: 11
End Page: 19
Language: English
ACCESSION: ISI:000278079300002
DOI: 10.1053/j.seminoncol.2010.01.001
PROVIDER: wos
PUBMED: 20172358
Notes: --- - Review - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul Chapman
    326 Chapman